Building a new path to make medicines with AI
Isomorphic Labs is building AI-powered drug discovery end-to-end. Here's what the tech actually does — and where the…
Charles · Oct 10, 2026Researchers receive funding to launch USC’s first clinical study of psilocybin for mental health
USC launches its first psilocybin clinical study in 2026, testing whether mindfulness training can boost psychedelic therapy outcomes…
Charles · Oct 9, 2026GLP-1 treatment late in life extends lifespan in animal model
NIH-funded research shows semaglutide extended lifespan in older healthy mice — and the anti-aging implications go far beyond…
Charles · Oct 9, 2026Lab-Grown Meat Promises a Greener Plate but Faces Steep Hurdles, Major Review Finds
A major 2026 review confirms cultivated meat has real potential but faces serious scaling, cost, and consumer trust…
Charles · Oct 9, 2026Meet the Women Scientists Who Can Make Meat out of Thin Air
Women scientists are making protein from air and growing meat without killing animals. Here's where cultivated meat food…
Charles · Oct 3, 2026Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial | Communications Medicine
A 2026 pilot trial shows psilocybin-assisted therapy is safe and feasible for veterans with severe, treatment-resistant PTSD. Here's…
Charles · Aug 26, 2026Ocean Technology Development Tank
NOAA's 2-million-liter ocean tank in La Jolla is solving a real crisis in marine survey science — here's…
Charles · Aug 24, 2026AI-powered drug repurposing: Finding new uses for existing molecules
AI drug repurposing raised $8.9B in 2024 with zero FDA approvals. Here's what the hype is missing —…
Charles · Aug 24, 2026Gene-Edited CAR T Expands Rare Disease Horizons
Gene-edited CAR T therapy is opening rare disease treatment in 2026. Here's what CRISPR, AEGIS, and off-the-shelf T…
Charles · Aug 16, 2026